EAST RUTHERFORD, N.J. - Cambrex Corp., which makes active drug ingredients, on Thursday said Steven M. Klosk is its new president and chief executive.
| CBM | 2.91 |
Klosk replaces James A. Mack, president and CEO since 1995 and chairman since 1999. Mack will remain on the board until his retirement June 30.
The company said it is separating the positions of chairman and CEO. John R. Miller, currently lead director, will assume the role of non-executive chairman.
Klosk, 51, joined Cambrex in October 1992 as vice president of administration. Most recently, he served as executive vice president and chief operating officer.
Major U.S. stock indexes slumped further south midday Monday, further extending this morning's hefty losses which erased last week's f...
China markets opened lower on Tuesday morning as the investors' confidence hit by the signals that global recession are deepening.
African Eagle Resources has raised its stake in the Mokambo joint venture to 87% and says 2008 drill results were "promising".


Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Building your business and corporate credit for your small business.
Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!